Askpot
← Company directory

Tecnimede Group: SWOT analysis

Tecnimede Group is a pharmaceutical company established in 1980, fully funded by Portuguese private capital. It focuses on the development, production, and distribution of pharmaceutical products aimed at improving human health.

Strengths

  • Tecnimede Group has a robust research and development framework, allowing for continuous innovation in pharmaceutical solutions.

  • The company boasts a diverse product portfolio with over 130 products developed and marketed worldwide, catering to various healthcare needs.

  • With 100% Portuguese ownership, Tecnimede has a strong local commitment and understanding of the Portuguese market, enhancing its brand loyalty.

  • The company manages over 4000 Marketing Authorizations (MAs), demonstrating its extensive regulatory expertise and market reach.

  • Tecnimede's strong focus on quality and technological innovation positions it as a trusted provider in the pharmaceutical industry.

  • The company holds over 440 patents and 119 International Nonproprietary Names (INNs), showcasing its commitment to intellectual property and innovation.

  • Global partnerships across Europe, Africa, Asia, and the Americas enhance Tecnimede's market presence and collaborative opportunities.

  • The brand identity reflects a commitment to improving health through innovative pharmaceutical solutions, backed by local expertise.

Weaknesses

Sign in to access Weaknesses

This content is available to registered users.

Sign in

Opportunities

Sign in to access Opportunities

This content is available to registered users.

Sign in

Threats

Sign in to access Threats

This content is available to registered users.

Sign in